Concepedia

Ronald Scotland

RS

4

Publications

576

Citations

4

H-Index

2004

Active since

Affiliations

University of Southern California(Current)

Stanford University

Ronald Scotland is an author at University of Southern California specializing in radiation oncology, immunology, and medicine.

Top concepts

Publications per year

2004–2007

4

Publications

4

Autoimmunity in a Phase I Trial of a Fully Human Anti-Cytotoxic T-Lymphocyte Antigen-4 Monoclonal Antibody With Multiple Melanoma Peptides and Montanide ISA 51 for Patients With Resected Stages III and IV Melanoma

Kristin M. Sanderson, Ronald Scotland, Peter P. Lee et al. · Journal of Clinical Oncology · 2004 · 433 citations

Alum with Interleukin-12 Augments Immunity to a Melanoma Peptide Vaccine: Correlation with Time to Relapse in Patients with Resected High-Risk Disease

Omid Hamid, Jolie C. Solomon, Ronald Scotland et al. · Clinical Cancer Research · 2007 · 81 citations

Phase II trial of extended dose anti-CTLA-4 antibody ipilimumab (formerly MDX-010) with a multi-peptide vaccine for resected stages IIIC and IV melanoma

Jeffrey S. Weber, Ş. Targan, Ronald Scotland et al. · Journal of Clinical Oncology · 2006 · 39 citations

, , +22

Characterization of Long-Term Effector-Memory T-Cell Responses in Patients with Resected High-Risk Melanoma Receiving a Melanoma Peptide Vaccine

Brian Chiong, Raymond M.H. Wong, Peter P. Lee et al. · Journal of Immunotherapy · 2004 · 23 citations

, , +18

Rows per page

1–4 of 4